_id
690db372ccc777a4e85d0ce7
Ticker
AVCNF
Name
Avicanna Inc
Exchange
OTCQX
Address
480 University Avenue, Toronto, ON, Canada, M5G 1V2
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.avicanna.com
Description
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, such as Trunerox, an adjuvant treatment for seizure associated with Lennox-Gastaut Syndrome and Dravet Syndrome. The company also offers active pharmaceutical ingredients comprising various cannabidiol, tetrahydrocannabinol, and cannabigerol flower for use in the development and production of food, cosmetics, medical, and pharmaceutical products under the Aureus Santa Marta brand. In addition, it operates MyMedi.ca, a medical cannabis care platform that offers a diverse portfolio of products and bilingual pharmacist-led patient support programs, specialty services to veterans, as well as provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens; and collaborates with public and private payers for adjudication and reimbursement. The company has a research and collaboration agreement with a multinational European based pharmaceutical company to assess its proprietary SEDDS technology in combination with Collaborator's various drug delivery and pharmaceutical formats. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.
Last Close
0.156
Volume
5000
Current Price
0.156
Change
-0.0023
Last Updated
2026-01-20T15:59:21.948Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
19181626
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
6396822
Cost Of Revenue
3247542
Gross Profit
3149280
Operating Expenses
7769622
Operating Income
-1372800
Interest Expense
5817
Pretax Income
-1382894
Net Income
-1382894
Eps
-0.01173861421208482
Dividends Per Share
-
Shares Outstanding
117807262
Income Tax Expense
-
EBITDA
-
Operating Margin
-21.460656557271722
Total Other Income Expense Net
-4277
Cash
464848
Short Term Investments
-
Receivables
2480440
Inventories
4555348
Total Current Assets
7863361
Property Plant Equipment
12288268
Total Assets
21172683
Payables
8120815
Short Term Debt
-
Long Term Debt
-
Total Liabilities
9468510
Equity
3110351
Bs_currency_symbol
CAD
Depreciation
193891
Change In Working Capital
61527
Cash From Operations
-842522
Capital Expenditures
22670
Cash From Investing
-
Cash From Financing
1011579
Net Change In Cash
146429
Cf_currency_symbol
CAD
PE
-
PB
5.908636315322611
ROE
-44.46102706736313
ROA
-6.531500991159221
FCF
-865192
Fcf Percent
-0.13525341177228317
Piotroski FScore
1
Health Score
12
Deep Value Investing Score
2
Defensive Investing Score
4
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
6396822
Quarters > 0 > income Statement > cost Of Revenue
3247542
Quarters > 0 > income Statement > gross Profit
3149280
Quarters > 0 > income Statement > operating Expenses
7769622
Quarters > 0 > income Statement > operating Income
-1372800
Quarters > 0 > income Statement > interest Expense
5817
Quarters > 0 > income Statement > pretax Income
-1382894
Quarters > 0 > income Statement > net Income
-1382894
Quarters > 0 > income Statement > eps
-0.01173861421208482
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
117807262
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-21.460656557271722
Quarters > 0 > income Statement > total Other Income Expense Net
-4277
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
464848
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2480440
Quarters > 0 > balance Sheet > inventories
4555348
Quarters > 0 > balance Sheet > total Current Assets
7863361
Quarters > 0 > balance Sheet > property Plant Equipment
12288268
Quarters > 0 > balance Sheet > total Assets
21172683
Quarters > 0 > balance Sheet > payables
8120815
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
9468510
Quarters > 0 > balance Sheet > equity
3110351
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-1382894
Quarters > 0 > cash Flow > depreciation
193891
Quarters > 0 > cash Flow > change In Working Capital
61527
Quarters > 0 > cash Flow > cash From Operations
-842522
Quarters > 0 > cash Flow > capital Expenditures
22670
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
1011579
Quarters > 0 > cash Flow > net Change In Cash
146429
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.01173861421208482
Quarters > 0 > ratios > PB
5.908636315322611
Quarters > 0 > ratios > ROE
-44.46102706736313
Quarters > 0 > ratios > ROA
-6.531500991159221
Quarters > 0 > ratios > FCF
-865192
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.13525341177228317
Quarters > 0 > health Score
12
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
6157309
Quarters > 1 > income Statement > cost Of Revenue
3029638
Quarters > 1 > income Statement > gross Profit
3127671
Quarters > 1 > income Statement > operating Expenses
6857279
Quarters > 1 > income Statement > operating Income
-699970
Quarters > 1 > income Statement > interest Expense
3064
Quarters > 1 > income Statement > pretax Income
-701178
Quarters > 1 > income Statement > net Income
-701178
Quarters > 1 > income Statement > eps
-0.006161100686175897
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
113807262
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-11.368115519295849
Quarters > 1 > income Statement > total Other Income Expense Net
1856
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
207639
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2818089
Quarters > 1 > balance Sheet > inventories
4385251
Quarters > 1 > balance Sheet > total Current Assets
7680610
Quarters > 1 > balance Sheet > property Plant Equipment
11710773
Quarters > 1 > balance Sheet > total Assets
20473059
Quarters > 1 > balance Sheet > payables
8018579
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
9619871
Quarters > 1 > balance Sheet > equity
2548687
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-701178
Quarters > 1 > cash Flow > depreciation
191570
Quarters > 1 > cash Flow > change In Working Capital
307688
Quarters > 1 > cash Flow > cash From Operations
-129976
Quarters > 1 > cash Flow > capital Expenditures
85300
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-9515
Quarters > 1 > cash Flow > net Change In Cash
-224758
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.006161100686175897
Quarters > 1 > ratios > PB
6.965913378928052
Quarters > 1 > ratios > ROE
-27.511342114586846
Quarters > 1 > ratios > ROA
-3.424881450300124
Quarters > 1 > ratios > FCF
-215276
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.03496267606514469
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
6324201
Quarters > 2 > income Statement > cost Of Revenue
2720134
Quarters > 2 > income Statement > gross Profit
3604067
Quarters > 2 > income Statement > operating Expenses
6230007
Quarters > 2 > income Statement > operating Income
94194
Quarters > 2 > income Statement > interest Expense
31625
Quarters > 2 > income Statement > pretax Income
74721
Quarters > 2 > income Statement > net Income
74721
Quarters > 2 > income Statement > eps
0.0006679824457420819
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
111860724
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
1.48942135140866
Quarters > 2 > income Statement > total Other Income Expense Net
12152
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
456759
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2391187
Quarters > 2 > balance Sheet > inventories
4347042
Quarters > 2 > balance Sheet > total Current Assets
7614519
Quarters > 2 > balance Sheet > property Plant Equipment
11988475
Quarters > 2 > balance Sheet > total Assets
20745292
Quarters > 2 > balance Sheet > payables
7345680
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
9920039
Quarters > 2 > balance Sheet > equity
3021989
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
74721
Quarters > 2 > cash Flow > depreciation
192993
Quarters > 2 > cash Flow > change In Working Capital
-390559
Quarters > 2 > cash Flow > cash From Operations
-17685
Quarters > 2 > cash Flow > capital Expenditures
140025
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
30632
Quarters > 2 > cash Flow > net Change In Cash
-126078
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
0.0006679824457420819
Quarters > 2 > ratios > PB
5.774432979074378
Quarters > 2 > ratios > ROE
2.472576835984512
Quarters > 2 > ratios > ROA
0.3601829272877914
Quarters > 2 > ratios > FCF
-157710
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.02493753756403378
Quarters > 2 > health Score
28
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
6616855
Quarters > 3 > income Statement > cost Of Revenue
3166666
Quarters > 3 > income Statement > gross Profit
3450189
Quarters > 3 > income Statement > operating Expenses
7837628
Quarters > 3 > income Statement > operating Income
-1220773
Quarters > 3 > income Statement > interest Expense
21986
Quarters > 3 > income Statement > pretax Income
131518
Quarters > 3 > income Statement > net Income
131518
Quarters > 3 > income Statement > eps
0.001193280545230076
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
110215490
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-18.44944463797378
Quarters > 3 > income Statement > total Other Income Expense Net
1374277
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
448028
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
2951968
Quarters > 3 > balance Sheet > inventories
3974571
Quarters > 3 > balance Sheet > total Current Assets
7641172
Quarters > 3 > balance Sheet > property Plant Equipment
11272839
Quarters > 3 > balance Sheet > total Assets
20116932
Quarters > 3 > balance Sheet > payables
7771623
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
10375318
Quarters > 3 > balance Sheet > equity
2312859
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
131518
Quarters > 3 > cash Flow > depreciation
191359
Quarters > 3 > cash Flow > change In Working Capital
-123002
Quarters > 3 > cash Flow > cash From Operations
-240873
Quarters > 3 > cash Flow > capital Expenditures
307136
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
596328
Quarters > 3 > cash Flow > net Change In Cash
48319
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
0.001193280545230076
Quarters > 3 > ratios > PB
7.433923313094313
Quarters > 3 > ratios > ROE
5.68638209246651
Quarters > 3 > ratios > ROA
0.653767681871172
Quarters > 3 > ratios > FCF
-548009
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.08282016154200145
Quarters > 3 > health Score
28
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
25459215
Annuals > 0 > income Statement > cost Of Revenue
12560903
Annuals > 0 > income Statement > gross Profit
12898312
Annuals > 0 > income Statement > operating Expenses
30139357
Annuals > 0 > income Statement > operating Income
-4680142
Annuals > 0 > income Statement > interest Expense
333647
Annuals > 0 > income Statement > pretax Income
-3617681
Annuals > 0 > income Statement > net Income
-3617681
Annuals > 0 > income Statement > eps
-0.03282370744801842
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
110215490
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-18.382899865530025
Annuals > 0 > income Statement > total Other Income Expense Net
1396108
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
448028
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2951968
Annuals > 0 > balance Sheet > inventories
3974571
Annuals > 0 > balance Sheet > total Current Assets
7641172
Annuals > 0 > balance Sheet > property Plant Equipment
11272839
Annuals > 0 > balance Sheet > total Assets
20116932
Annuals > 0 > balance Sheet > payables
7771623
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
10375318
Annuals > 0 > balance Sheet > equity
2312859
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-3617681
Annuals > 0 > cash Flow > depreciation
853737
Annuals > 0 > cash Flow > change In Working Capital
-790391
Annuals > 0 > cash Flow > cash From Operations
-2547108
Annuals > 0 > cash Flow > capital Expenditures
402574
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
3407430
Annuals > 0 > cash Flow > net Change In Cash
457748
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.03282370744801842
Annuals > 0 > ratios > PB
7.433923313094313
Annuals > 0 > ratios > ROE
-156.41597693590487
Annuals > 0 > ratios > ROA
-17.98326404841454
Annuals > 0 > ratios > FCF
-2949682
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.1158591103457039
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
16791483
Annuals > 1 > income Statement > cost Of Revenue
10132791
Annuals > 1 > income Statement > gross Profit
6658692
Annuals > 1 > income Statement > operating Expenses
25171118
Annuals > 1 > income Statement > operating Income
-8379635
Annuals > 1 > income Statement > interest Expense
610256
Annuals > 1 > income Statement > pretax Income
-8743003
Annuals > 1 > income Statement > net Income
-8743003
Annuals > 1 > income Statement > eps
-0.0964192241582314
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
90676969
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-49.90407934784557
Annuals > 1 > income Statement > total Other Income Expense Net
246888
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
477198
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
2936925
Annuals > 1 > balance Sheet > inventories
4544238
Annuals > 1 > balance Sheet > total Current Assets
8460356
Annuals > 1 > balance Sheet > property Plant Equipment
11990300
Annuals > 1 > balance Sheet > total Assets
21971108
Annuals > 1 > balance Sheet > payables
8870149
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
13998997
Annuals > 1 > balance Sheet > equity
-112504
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-8743003
Annuals > 1 > cash Flow > depreciation
777288
Annuals > 1 > cash Flow > change In Working Capital
4356696
Annuals > 1 > cash Flow > cash From Operations
-1404218
Annuals > 1 > cash Flow > capital Expenditures
557560
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
3554472
Annuals > 1 > cash Flow > net Change In Cash
-896962
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.0964192241582314
Annuals > 1 > ratios > PB
-125.7342597952073
Annuals > 1 > ratios > ROE
7771.281909976534
Annuals > 1 > ratios > ROA
-39.79318202796145
Annuals > 1 > ratios > FCF
-1961778
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.11683172951430199
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
4047881
Annuals > 2 > income Statement > cost Of Revenue
2932540
Annuals > 2 > income Statement > gross Profit
1115341
Annuals > 2 > income Statement > operating Expenses
14458301
Annuals > 2 > income Statement > operating Income
-10410420
Annuals > 2 > income Statement > interest Expense
1671843
Annuals > 2 > income Statement > pretax Income
-14735291
Annuals > 2 > income Statement > net Income
-14735291
Annuals > 2 > income Statement > eps
-0.19659426999391616
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
74952800
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-12176116
Annuals > 2 > income Statement > operating Margin
-257.1819675528999
Annuals > 2 > income Statement > total Other Income Expense Net
-2653028
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
1194040
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
2121619
Annuals > 2 > balance Sheet > inventories
3240029
Annuals > 2 > balance Sheet > total Current Assets
7064418
Annuals > 2 > balance Sheet > property Plant Equipment
10387185
Annuals > 2 > balance Sheet > total Assets
17619231
Annuals > 2 > balance Sheet > payables
4752796
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
179551
Annuals > 2 > balance Sheet > total Liabilities
14160580
Annuals > 2 > balance Sheet > equity
-383560
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-14735291
Annuals > 2 > cash Flow > depreciation
887332
Annuals > 2 > cash Flow > change In Working Capital
1430114
Annuals > 2 > cash Flow > cash From Operations
-7435368
Annuals > 2 > cash Flow > capital Expenditures
66780
Annuals > 2 > cash Flow > cash From Investing
810236
Annuals > 2 > cash Flow > cash From Financing
9901485
Annuals > 2 > cash Flow > net Change In Cash
3276353
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.19659426999391616
Annuals > 2 > ratios > PB
-30.48450516216498
Annuals > 2 > ratios > ROE
3841.717332359996
Annuals > 2 > ratios > ROA
-83.63186225323909
Annuals > 2 > ratios > FCF
-7502148
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1.8533519142484673
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3268906
Annuals > 3 > income Statement > cost Of Revenue
437086
Annuals > 3 > income Statement > gross Profit
2831820
Annuals > 3 > income Statement > operating Expenses
14682315
Annuals > 3 > income Statement > operating Income
-11413409
Annuals > 3 > income Statement > interest Expense
738056
Annuals > 3 > income Statement > pretax Income
-16760773
Annuals > 3 > income Statement > net Income
-16774540
Annuals > 3 > income Statement > eps
-0.36558357827196686
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
45884282
Annuals > 3 > income Statement > income Tax Expense
13767
Annuals > 3 > income Statement > EBITDA
-15128730
Annuals > 3 > income Statement > operating Margin
-349.1507250437914
Annuals > 3 > income Statement > total Other Income Expense Net
-4609308
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
31004
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
1130087
Annuals > 3 > balance Sheet > inventories
3002059
Annuals > 3 > balance Sheet > total Current Assets
7353630
Annuals > 3 > balance Sheet > property Plant Equipment
14468789
Annuals > 3 > balance Sheet > total Assets
22301614
Annuals > 3 > balance Sheet > payables
7289380
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
415826
Annuals > 3 > balance Sheet > total Liabilities
15393592
Annuals > 3 > balance Sheet > equity
1146187
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-16774540
Annuals > 3 > cash Flow > depreciation
756182
Annuals > 3 > cash Flow > change In Working Capital
-2449012
Annuals > 3 > cash Flow > cash From Operations
-11663025
Annuals > 3 > cash Flow > capital Expenditures
769166
Annuals > 3 > cash Flow > cash From Investing
760828
Annuals > 3 > cash Flow > cash From Financing
10060016
Annuals > 3 > cash Flow > net Change In Cash
-1235728
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-0.36558357827196686
Annuals > 3 > ratios > PB
6.245008879004909
Annuals > 3 > ratios > ROE
-1463.5081361069354
Annuals > 3 > ratios > ROA
-75.21670853060232
Annuals > 3 > ratios > FCF
-12432191
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-3.803165646243728
Annuals > 3 > health Score
8
Valuation > metrics > PE
-0.01173861421208482
Valuation > metrics > PB
5.908636315322611
Valuation > final Score
20.91363684677389
Valuation > verdict
97.0% Overvalued
Profitability > metrics > ROE
-44.46102706736313
Profitability > metrics > ROA
-17.586551094373004
Profitability > metrics > Net Margin
-0.2161845366339723
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.0441934045385874
Risk > metrics > Interest Coverage
-235.99793708096956
Risk > final Score
-938
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.9682970243750165
Liquidity > metrics > Quick Ratio
0.40734987806026857
Liquidity > final Score
30
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
42.25567020925622
Prev Valuations > 2
40
Prev Profitabilities > 0
0
Prev Profitabilities > 1
10
Prev Profitabilities > 2
20
Prev Risks > 0
-908
Prev Risks > 1
18
Prev Risks > 2
-216
Prev Liquidities > 0
31
Prev Liquidities > 1
48
Prev Liquidities > 2
34
Updated At
2026-01-20T21:26:24.920Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-09
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-12-31
Earnings History > 1 > report Date
2022-03-30
Earnings History > 1 > date
2021-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
CAD
Earnings History > 1 > eps Actual
-0.18
Earnings History > 1 > eps Estimate
-0.06
Earnings History > 1 > eps Difference
-0.12
Earnings History > 1 > surprise Percent
-200
Earnings History > 2 > period
2021-06-30
Earnings History > 2 > report Date
2021-09-08
Earnings History > 2 > date
2021-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
CAD
Earnings History > 2 > eps Actual
-0.18
Earnings History > 2 > eps Estimate
-0.08
Earnings History > 2 > eps Difference
-0.1
Earnings History > 2 > surprise Percent
-125
Earnings History > 3 > period
2021-03-31
Earnings History > 3 > report Date
2021-06-30
Earnings History > 3 > date
2021-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
CAD
Earnings History > 3 > eps Actual
-0.0541
Earnings History > 3 > eps Estimate
-0.04
Earnings History > 3 > eps Difference
-0.0141
Earnings History > 3 > surprise Percent
-35.25
Earnings History > 4 > period
2020-12-31
Earnings History > 4 > report Date
2021-03-31
Earnings History > 4 > date
2020-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.0679
Earnings History > 4 > eps Estimate
-0.08
Earnings History > 4 > eps Difference
0.0121
Earnings History > 4 > surprise Percent
15.125
Earnings History > 5 > period
2020-09-30
Earnings History > 5 > report Date
2020-11-11
Earnings History > 5 > date
2020-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.35
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-06-30
Earnings History > 6 > report Date
2020-08-14
Earnings History > 6 > date
2020-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.23
Earnings History > 6 > eps Estimate
-0.26
Earnings History > 6 > eps Difference
0.03
Earnings History > 6 > surprise Percent
11.5385
Earnings History > 7 > period
2020-03-31
Earnings History > 7 > report Date
2020-04-15
Earnings History > 7 > date
2020-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.34
Earnings History > 7 > eps Estimate
-0.15
Earnings History > 7 > eps Difference
-0.19
Earnings History > 7 > surprise Percent
-126.6667
Earnings History > 8 > period
2019-12-31
Earnings History > 8 > report Date
2020-03-31
Earnings History > 8 > date
2019-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.0653
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-09-30
Earnings History > 9 > report Date
2019-11-14
Earnings History > 9 > date
2019-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.2508
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-06-30
Earnings History > 10 > report Date
2019-08-14
Earnings History > 10 > date
2019-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.2099
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.2099
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-03-31
Earnings History > 11 > report Date
2019-06-30
Earnings History > 11 > date
2019-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.1927
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.1927
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-12-31
Earnings History > 12 > report Date
2019-03-31
Earnings History > 12 > date
2018-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.1747
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.1747
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-09-30
Earnings History > 13 > report Date
2018-12-31
Earnings History > 13 > date
2018-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.1608
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.1608
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-06-30
Earnings History > 14 > report Date
2018-09-30
Earnings History > 14 > date
2018-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.1183
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.1183
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2018-03-31
Earnings History > 15 > report Date
2018-06-30
Earnings History > 15 > date
2018-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CAD
Earnings History > 15 > eps Actual
-0.0845
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0845
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-12-31
Earnings History > 16 > report Date
2018-03-31
Earnings History > 16 > date
2017-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
CAD
Earnings History > 16 > eps Actual
-0.0126
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0126
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-09-30
Earnings History > 17 > report Date
2017-12-31
Earnings History > 17 > date
2017-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
CAD
Earnings History > 17 > eps Actual
-0.1006
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.1006
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2017-06-30
Earnings History > 18 > report Date
2017-09-30
Earnings History > 18 > date
2017-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
CAD
Earnings History > 18 > eps Actual
-0.0456
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0456
Earnings History > 18 > surprise Percent
-
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, such as Trunerox, an adjuvant treatment for seizure associated with Lennox-Gastaut Syndrome and Dravet Syndrome. The company also offers active pharmaceutical ingredients comprising various cannabidiol, tetrahydrocannabinol, and cannabigerol flower for use in the development and production of food, cosmetics, medical, and pharmaceutical products under the Aureus Santa Marta brand. In addition, it operates MyMedi.ca, a medical cannabis care platform that offers a diverse portfolio of products and bilingual pharmacist-led patient support programs, specialty services to veterans, as well as provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens; and collaborates with public and private payers for adjudication and reimbursement. The company has a research and collaboration agreement with a multinational European based pharmaceutical company to assess its proprietary SEDDS technology in combination with Collaborator's various drug delivery and pharmaceutical formats. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAvicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order TradingView — Track All Markets
Read more →(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Avicanna Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2021-12-31
EPS Actual
-0.18
EPS Estimate
-0.06
EPS Difference
-0.12
Surprise Percent
-200%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.